Evotec SE (EVO) Net Shares Issued and Repurchased (2009 - 2025)
Evotec SE (EVO) reported Net Shares Issued and Repurchased of $3.4 for Q2 2025, up 5.11% on a YoY basis from $3.23 in Q2 2024, and down 98.46% sequentially from $220.9 in Q1 2025.
Evotec SE (EVO) Net Shares Issued and Repurchased (2009 - 2025) Analysis & Trends
Evotec SE (EVO) has 4 years of Net Shares Issued and Repurchased data on file, last reported at $3.4 in Q2 2025.
- For the quarter ending Q2 2025, Net Shares Issued and Repurchased rose 5.11% year-over-year to $3.4; the trailing twelve-month figure through Jun 2025 stood at $624.04 (up 56.11% YoY), and the FY2009 full-year result was -$61377.8, changed N/A from the prior year.
- Net Shares Issued and Repurchased declined to $3.4 in Q2 2025, from $220.9 in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $396.52 in Q1 2024 to a low of $3.23 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.40 |
| Jun 30, 2025 | 3.40 |
| Mar 31, 2025 | 220.90 |
| Mar 31, 2025 | 220.90 |
| Jun 30, 2024 | 3.23 |
| Jun 30, 2024 | 3.23 |
| Mar 31, 2024 | 396.52 |
| Mar 31, 2024 | 396.52 |
| Mar 31, 2010 | -132.93 |
| Mar 31, 2010 | -132.93 |
| Dec 31, 2009 | -64,911.33 |
| Dec 31, 2009 | -64,911.33 |
| Mar 31, 2009 | 57.54 |
| Mar 31, 2009 | 57.54 |